Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1
about
HBV induced HCC: major risk factors from genetic to molecular levelBioinformatics analysis of the proteins interacting with LASP-1 and their association with HBV-related hepatocellular carcinoma.HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis.The hepatitis B virus-associated tumor microenvironment in hepatocellular carcinoma.Chronic hepatitis B virus infection and occurrence of hepatocellular carcinoma in tree shrews (Tupaia belangeri chinensis)Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.Hepatitis B virus (HBV) receptors: Deficiency in tumor results in scant HBV infection and overexpression in peritumor leads to higher recurrence risk.Dose-response association between hepatitis B surface antigen levels and liver cancer risk in Chinese men and womenSTAT3 as a potential therapeutic target in ALDH+ and CD44+/CD24+ stem cell-like pancreatic cancer cellsIncreased ERp57 Expression in HBV-Related Hepatocellular Carcinoma: Possible Correlation and Prognosis.A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells.Modulation of Wnt signaling pathway by hepatitis B virus.Reduced HBV cccDNA and HBsAg in HBV-associated hepatocellular carcinoma tissuesIdentification of serum β-catenin as a biomarker in patients with HBV-related liver diseases
P2860
Q26825274-5B8D1DF2-B36C-412B-9B2A-5AD747C5E28BQ30008764-2B7132B7-E6B7-4226-80E0-610D54FBE8CCQ30240015-0147797D-4AD8-4396-B9E7-7E17E9C5F845Q35136610-DFA0CAAF-82CD-4654-BA17-481FD872B183Q35204227-FC770131-5F23-4FF1-9B3D-F248B668C735Q36278139-7583CF81-86D5-487A-9179-6A093BCDD424Q36619079-317D2671-0559-431C-9AEF-9F9D8049F9CDQ37176658-1E3D3471-3A66-463C-99EA-7CAA83E0E70DQ37427042-36CF864A-360A-4AC0-9BDD-911B3C71A269Q37714710-817F8339-6A51-4412-8501-8923EE9F1ACBQ38948041-B42D9B80-3FE5-4085-B9EB-58C1438A61BCQ39419969-0212C8E7-DBDE-4B97-993D-8DBB0717C72DQ58774311-33617FD8-9AC0-44D1-97C3-F4CF7C50DA56Q58795782-86F08004-1789-4BE3-BD6E-CA9279222C1A
P2860
Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1
description
2009 nî lūn-bûn
@nan
2009 թուականին հրատարակուած գիտական յօդուած
@hyw
2009 թվականին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@ast
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@en
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@en-gb
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@nl
type
label
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@ast
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@en
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@en-gb
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@nl
prefLabel
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@ast
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@en
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@en-gb
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@nl
P2093
P2860
P3181
P356
P1476
Role of hepatitis B surface an ...... hoid enhancer-binding factor 1
@en
P2093
Da-Fang Wan
Xiaochen Tian
Yu-Mei Wen
Zhang-Mei Ma
P2860
P2888
P3181
P356
10.1186/1756-9966-28-58
P407
P577
2009-01-01T00:00:00Z
P5875
P6179
1009470350